167 related articles for article (PubMed ID: 32054948)
21. MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway.
Lu L; Liu Q; Wang P; Wu Y; Liu X; Weng C; Fang X; Li B; Cao X; Mao H; Wang L; Guan M; Wang W; Liu G
BMC Cancer; 2019 Mar; 19(1):209. PubMed ID: 30849960
[TBL] [Abstract][Full Text] [Related]
22. MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.
Wen XP; Ma HL; Zhao LY; Zhang W; Dang CX
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):78-85. PubMed ID: 26025408
[TBL] [Abstract][Full Text] [Related]
23. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
24. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
Manfè V; Biskup E; Rosbjerg A; Kamstrup M; Skov AG; Lerche CM; Lauenborg BT; Odum N; Gniadecki R
PLoS One; 2012; 7(1):e29541. PubMed ID: 22235305
[TBL] [Abstract][Full Text] [Related]
25. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
[TBL] [Abstract][Full Text] [Related]
26. miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway.
Xia L; Wu L; Xia H; Bao J; Li Q; Chen X; Xia R
Cell Cycle; 2019 Jul; 18(14):1635-1645. PubMed ID: 31213131
[TBL] [Abstract][Full Text] [Related]
27. Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells.
Chakraborty S; Mazumdar M; Mukherjee S; Bhattacharjee P; Adhikary A; Manna A; Chakraborty S; Khan P; Sen A; Das T
FEBS Lett; 2014 Feb; 588(4):549-59. PubMed ID: 24444609
[TBL] [Abstract][Full Text] [Related]
28. Multiple Copies in T-Cell Malignancy 1 (MCT-1) Promotes the Stemness of Non-Small Cell Lung Cancer Cells via Activating Interleukin-6 (IL-6) Signaling through Suppressing MiR-34a Expression.
Li Y; Wang B; Gui S; Ji J
Med Sci Monit; 2019 Dec; 25():10198-10204. PubMed ID: 31891569
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of miR-4286 is an unfavorable prognostic marker in individuals with non-small cell lung cancer.
An X; Ge J; Guo H; Mi H; Zhou J; Liu Y; Weiyue ; Wu Z
J Cell Biochem; 2019 Oct; 120(10):17573-17583. PubMed ID: 31111550
[TBL] [Abstract][Full Text] [Related]
30. Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma.
Sun D; Wu Y; Zhang S; Han Y; Shen J; Zheng W; Wei L; Liu Y; Ren L; Gu Z; Liu Y; Liu S; Ding C
Biomed Pharmacother; 2021 Oct; 142():111967. PubMed ID: 34467896
[TBL] [Abstract][Full Text] [Related]
31. Abberent expression of oncogenic and tumor-suppressive microRNAs and their target genes in human adenocarcinoma alveolar basal epithelial cells.
Tafsiri E; Darbouy M; Shadmehr MB; Cho WC; Karimipoor M
J Cancer Res Ther; 2016; 12(1):395-400. PubMed ID: 27072269
[TBL] [Abstract][Full Text] [Related]
32. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
33. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
Feng H; Ge F; Du L; Zhang Z; Liu D
J Cell Mol Med; 2019 Aug; 23(8):5282-5291. PubMed ID: 31199581
[TBL] [Abstract][Full Text] [Related]
34. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis.
Li S; Mei Z; Hu HB; Zhang X
J Cell Physiol; 2018 Sep; 233(9):6679-6688. PubMed ID: 29215698
[TBL] [Abstract][Full Text] [Related]
35. Endogenous microRNA-424 predicts clinical outcome and its inhibition acts as cancer suppressor in human non-small cell lung cancer.
Wang Y; Lv Z; Fu J; Wang Z; Fan Z; Lei T
Biomed Pharmacother; 2017 May; 89():208-214. PubMed ID: 28231541
[TBL] [Abstract][Full Text] [Related]
36. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of miR-4443 promotes the resistance of non-small cell lung cancer cells to epirubicin by targeting INPP4A and regulating the activation of JAK2/STAT3 pathway.
Zhang W; Qiao B; Fan J
Pharmazie; 2018 Jul; 73(7):386-392. PubMed ID: 30001772
[TBL] [Abstract][Full Text] [Related]
38. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.
Cheng R; Lu C; Zhang G; Zhang G; Zhao G
Oncol Rep; 2017 Apr; 37(4):2129-2136. PubMed ID: 28350100
[TBL] [Abstract][Full Text] [Related]
40. PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer.
Xiong S; Zheng Y; Jiang P; Liu R; Liu X; Qian J; Gu J; Chang L; Ge D; Chu Y
Br J Cancer; 2014 Jan; 110(2):353-62. PubMed ID: 24281003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]